# Michele Mercuri

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michele-mercuri/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,952 |
| Field | Atrial Fibrillation Management and Outcomes |
| h-index | 55 |
| i10-index | 129 |
| Last Known Institution | Alexion Pharma (Switzerland) |
| OpenAlex ID | https://openalex.org/A5078033695 |
| ORCID iD | https://orcid.org/0000-0002-5217-6644 |
| Works | 256 |

## Researcher papers

- [Edoxaban versus Warfarin in Patients with Atrial Fibrillation](https://scholariq.org/papers/edoxaban-versus-warfarin-in-patients-with-atrial-fibrillation/)
- [Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48](https://scholariq.org/papers/performance-of-the-abc-scores-for-assessing-the-risk-of-stroke-or-systemic/)

## Researcher topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Cardiovascular Health and Disease Prevention](https://scholariq.org/topics/cardiovascular-health-and-disease-prevention/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management-2/)
- [Cerebrovascular and Carotid Artery Diseases](https://scholariq.org/topics/cerebrovascular-and-carotid-artery-diseases/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

## Researcher university

- [Alexion Pharma (Switzerland)](https://scholariq.org/institutions/alexion-pharma-switzerland/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.